How to Buy Bolt Biotherapeutics Stock
Bolt Biotherapeutics Inc
Bolt Biotherapeutics, Inc. , a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system.
Bolt Biotherapeutics stock last closed at $0.34, down 2.57% from the previous day, and has decreased 69.28% in one year. It has overperformed other stocks in the Biotechnology industry by 0.08 percentage points. Bolt Biotherapeutics stock is currently +13.67% from its 52-week low of $0.30, and -74.46% from its 52-week high of $1.34.
At the moment, there are 38.34M BOLT shares outstanding. The market capitalization of BOLT is $13.07M. In the last 24 hours, 99,874 BOLT shares were traded.
How to Buy Bolt Biotherapeutics Stock
Not sure how to invest in Bolt Biotherapeutics stock? Here's how.
- Choose where to buy Bolt Biotherapeutics stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Bolt Biotherapeutics stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Pick your method of payment and add your info.
- Evaluate Bolt Biotherapeutics stock: The Bolt Biotherapeutics ticker symbol is BOLT. Is Bolt Biotherapeutics stock a good investment? Should you buy shares of BOLT? How do BOLT's underlying business fundamentals look? Do top analysts think Bolt Biotherapeutics is a good buy? Why has BOLT's stock price moved recently? (Hint: Our stock research website can help you understand if BOLT is a good stock to buy).
- Make your BOLT buy order: Decide if you will purchase BOLT shares at the current market price or use a limit order to purchase BOLT stock at a given price.
- Monitor your investment in BOLT: Create a watchlist to keep tabs on your new investment in Bolt Biotherapeutics stock.
Step 1: Choose where to buy Bolt Biotherapeutics stock
You will need an online brokerage account to access the NASDAQ market and buy BOLT shares.
Our recommended brokerage: eToro
We believe that eToro is the best place to buy stocks. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Technology to Energy, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected your brokerage, you need to fill out some personal details so you can buy BOLT today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create a new brokerage account.
- Send your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have opened your account on the best stock app for beginners, you can securely and quickly fund your account:
Watch the video below for more details transferring money into your new investment account.
Step 4: Evaluate Bolt Biotherapeutics stock
Once you have decided on the best place to buy Bolt Biotherapeutics stock, it's absolutely critical to analyze their stock before you invest, so you actually comprehend the risk as well as the opportunity.
Bolt Biotherapeutics shares quick numbers
BOLT Due Diligence Checks
WallStreetZen was built to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on BOLT's stock page.
Is BOLT stock properly valued?
You can use many financial metrics, analyses, models, and charts to gauge BOLT's true value.
Using relative valuations methods:
- BOLT could be undervalued based on its P/B ratio of 0.23x, relative to Biotechnology industry P/B ratio of 4.04x
You can access additional valuation analysis on BOLT's stock here.
A look at BOLT Cashflows and Balance Sheet
Passed Health Checks:
- There are more short-term assets than long-term liabilities on the BOLT balance sheet.
- There are more short-term assets than short-term liabilities on the BOLT balance sheet.
- Total BOLT debt is lower than 5 years ago, relative to shareholder equity.
Failed Health Checks:
- BOLT profit margin has gone up by 0.58 percentage points in the past year, but the company is still unprofitable.
- BOLT has a relatively high debt to equity ratio of 0.74.
- BOLT has cash burn of 61182000. It does not have enough cash and short-term investments to cover this.
- BOLT has $48.11M in cash and short term investments. This is not enough to cover its annual cash burn of $61.18M.
Do Wall Street analysts think it's a good time to buy Bolt Biotherapeutics stock
Out of 1 Wall Street analysts who monitor BOLT, the consensus analyst rating on Bolt Biotherapeutics is a Hold
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Bolt Biotherapeutics stock forecast page.
BOLT Momentum
BOLT Performance Metrics
Last year, BOLT revenue was $7.69M. In the past 5 year, BOLT's revenue has gone up by 104.5% per year. This was faster than the Biotechnology industry average of 44.31%.
You can research BOLT's earnings and revenue performance here.
Latest Insiders Trades at BOLT
Over the past year, insiders at BOLT have not bought or sold any shares.
Research more about who owns BOLT stock here.
Does BOLT provide a stable income stream?
No, Bolt Biotherapeutics doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your BOLT buy order
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally the easiest way to buy. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given dollar amount limit, use a limit order.
Click the Open button and eToro will execute the order.
If you want more help with investing in stocks on eToro, click the helpful video below:
Step 6: Monitor your investment in BOLT
Now that you own some shares in BOLT, you'll want to stay up-to-date on your new stock purchase.
Make a watchlist to track the latest developments regarding your BOLT stock.
BOLT Feed
How to Buy Stock in Bolt Biotherapeutics
To reiterate, here are the 6 steps to buy Bolt Biotherapeutics stock:
- Choose where to buy Bolt Biotherapeutics stock
- Sign up for your brokerage account
- Deposit funds into your brokerage account
- Evaluate Bolt Biotherapeutics stock
- Make your BOLT buy order
- Monitor your investment in BOLT
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get updates on your investment in Bolt Biotherapeutics, add BOLT to your watchlist by clicking the button below.
Other Articles You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.